Logo-ipp
Submitted: 01 Nov 2021
Accepted: 28 Dec 2021
ePublished: 24 Apr 2022
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

  Abstract View: 926

Original

IL-17A rs2275913 gene polymorphism in patients with diabetic nephropathy

Akbar Nazarian 1,2 ORCID logo, Seyyedeh Mina Hejazian 1,2 ORCID logo, Elham Ahmadian 1 ORCID logo, Sepideh Zununi Vahed 1 ORCID logo, Mehdi Haghi 3 ORCID logo, Majid Mobasseri 4, Mohammadreza Ardalan 1* ORCID logo

1 Kidney Research Center, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
2 Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
3 Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran
4 Endocrine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
*Correspondence to Prof. Mohammadreza Ardalan, Emails: ardalanm@tbzmed. ac.ir, ardalan34@yahoo.com

Abstract

Introduction: Diabetic nephropathy (DN) is a major microvascular complication of diabetes, leading to end-stage renal disease (ESRD).

Objectives: The aim of this study was to investigate the association between the rs2275913 polymorphism of interleukin-17 (IL-17) gene and the incidence of kidney disease in patients with type 2 diabetes (T2D).

Patients and Methods: Blood samples were collected from 113 T2D patients including 56 patients with nephropathy and 57 patients without nephropathy. In addition, 150 healthy individuals were included in this study to compare the results. Gene study was conducted by restriction fragment length polymorphism-polymerase chain reaction (RFLP-PCR) method.

Results: The frequency of A allele of IL-17A (rs2275913) gene polymorphism was significantly higher in patients with DN compared to healthy controls (P=0.043). In addition, serum creatinine levels were significantly higher in DN patients regardless of their genotypes (P<0.001).

Conclusion: Our results showed that diabetic patients who carry at least one A allele of IL-17A (rs2275913) gene polymorphism may develop DN.

Keywords: Diabetes type 2, Gene polymorphism, Interleukin-17 A gene, Kidney disease, Diabetic nephropathy
Citation: Nazarian A, Hejazian SM, Ahmadian E, Zununi Vahed S, Haghi M, Mobasseri M, Ardalan M. IL-17A rs2275913 gene polymorphism in patients with diabetic nephropathy. Immunopathol Persa. 2022;x(x):e29320. DOI:10.34172/ ipp.2022.29320.
First Name
Last Name
Email Address
Comments
Security code


Abstract View: 927

Your browser does not support the canvas element.


PDF Download: 0

Your browser does not support the canvas element.